Year-end Sale % OFF 
Abstract
Vaccine induced erythema nodosum (EN) is well recognized. In this letter, we report a case of a patient who developed recurrent EN following vaccination with the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA (mRNA) vaccine. Clinicians should be aware that COVID-19 mRNA vaccines can be a possible cause of EN.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
